US Stock MarketDetailed Quotes

THAR Tharimmune

Watchlist
  • 2.965
  • -0.115-3.73%
Close Jun 18 16:00 ET
  • 2.890
  • -0.075-2.53%
Post 19:23 ET
2.33MMarket Cap-132P/E (TTM)

Tharimmune Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tharimmune Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-2.85

+96.75%
Analyst Rating

Buy

May 31, 2024

Tharimmune Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency:

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 0.000--
--2024/FY-- / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 0.000--
--2024/FY-- / 0.000--

Tharimmune Earnings Reports

  • Tharimmune | 10-Q: Quarterly report

    May 9 20:32

  • Tharimmune | 10-K: Annual report

    Feb 23 21:34

  • Tharimmune: Q3 2023 Earnings Report

    Nov 8, 2023 06:02

  • Hillstream BioPharma | 10-Q: Q2 2023 Earnings Report

    Aug 12, 2023 04:16

    • Read more

    Analysis

    Analyst Rating

    Updated: May 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg